FDA approves Sarepta's muscular dystrophy drug 05:49 arohi Business No comments Sarepta soared after the company gained FDA approval for its muscular dystrophy treatment. Yahoo Finance’s Anjalee Khemlani joins Seana Smith on The Ticker to discuss. from Yahoo Finance https://ift.tt/34kFWxA Share This: Facebook Twitter Google+ Stumble Digg Email ThisBlogThis!Share to XShare to Facebook
0 comments:
Post a Comment